8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.96%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-21.69%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-24.23%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.15%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-22.17%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-22.17%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.54%
10Y CAGR of 56.54% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
56.54%
5Y CAGR of 56.54% while 3391.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
56.54%
3Y CAGR of 56.54% while 3391.T is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
152.46%
10Y net income/share CAGR of 152.46% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
152.46%
Net income/share CAGR of 152.46% while 3391.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
152.46%
3Y net income/share CAGR of 152.46% while 3391.T is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
81.73%
Equity/share CAGR of 81.73% while 3391.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
81.73%
Equity/share CAGR of 81.73% while 3391.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
81.73%
Equity/share CAGR of 81.73% while 3391.T is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.71%
Inventory growth well above 3391.T's 1.18%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.66%
Asset growth above 1.5x 3391.T's 2.31%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.59%
BV/share growth above 1.5x 3391.T's 1.90%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-11.84%
We’re deleveraging while 3391.T stands at 554.10%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.